secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-02-10T23:59:59+00:00
Accession:  0001213900-26-014298
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 2.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX deconsolidates Israel subsidiary after insolvency proceedings
-------------------------------------------------------------------

- BiomX Ltd. (wholly owned subsidiary) filed for insolvency in Israel on Jan 25, 2026; trustee appointed.
- CEO Jonathan Solomon and CFO Marina Wolfson terminated as officers of BiomX Ltd. retroactive to Jan 25 (remain at parent).
- Company deconsolidated BiomX Ltd. effective Feb 4, 2026, deemed a significant disposition of assets.
- Pro forma shows cash of $5.4M, accumulated deficit of $205.6M; net loss for 9M 2025 reduced from $22.9M to $5.9M.
- Severance payments: 9 months for CEO, 6 months for CFO and CDO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026014298/0001213900-26-014298-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026014298/ea0276425-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-014298

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer